United States · Series A startup

Who invested in Recida Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$8.5Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $8.5MFeb 2019
Investors
1
See who backed them

The rounds

  1. Feb 2019
    Series A$8.5M

    Reported by Pehub

Founders and team

From the SEC filings it signed: 2 on the team.

  • Michael SavinoExecutive Officeri
  • Yigong GeExecutive Officer, Directori

On the board, as filediDavid SocksPatrick Heron

Everyone who backed them

Frazier Healthcare PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Recida Therapeutics

Who invested in Recida Therapeutics?

Recida Therapeutics's investors include Frazier Healthcare Partners.

How much has Recida Therapeutics raised?

Recida Therapeutics has raised $8.5M across 1 round since 2019.

When did Recida Therapeutics last raise?

Recida Therapeutics's most recent round was a Series A of $8.5M in Feb 2019.

What was Recida Therapeutics's biggest round?

Its most recent round, $8.5M in Feb 2019, is also its largest on record.

Who backed Recida Therapeutics first?

Recida Therapeutics's first round on record, in Feb 2019, was backed by Frazier Healthcare Partners.

What stage is Recida Therapeutics at?

Recida Therapeutics's latest named round is a Series A, in Feb 2019.

Where is Recida Therapeutics based?

Recida Therapeutics is based in the United States.

Companies like Recida Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.